US 11925626
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted A61KA61K31/437A61K47/10
Quick answer
US patent 11925626 (Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound) held by Corcept Therapeutics Incorporated expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/437, A61K47/10, A61K47/14, A61K47/22